重组乙型肝炎蛋白（大肠埃希菌，厦门万泰沧海）

N/A

Report date: 2025/06/23 14:00:55

Base Information

Drug Name重组乙型肝炎蛋白（大肠埃希菌，厦门万泰沧海）
Drug Alias Name重组乙型肝炎蛋白注射液（大肠埃希菌，厦门万泰沧海）
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesXiamen Innovax Biotech Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesXiamen Innovax Biotech Co LtdXiamen UniversityBeijing Wantai Biological Pharmacy Enterprise Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A